These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 13565615)

  • 1. Changes in the electroencephalogram caused by intravenous perphenazine in normal subjects and mental disease patients; preliminary note.
    NEGRI VU; BASEVI A
    Minerva Med; 1958 May; 49(39, Suppl.):1995-9. PubMed ID: 13565615
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of psychiatric disorders in mental defectives with perphenazine.
    SPROGIS GR; BABCOCK SD; SEGALL J
    J Med Soc N J; 1958 Mar; 55(3):120-3. PubMed ID: 13514429
    [No Abstract]   [Full Text] [Related]  

  • 3. Preliminary electroencephalographic findings in serapil therapy.
    HESS R
    Schweiz Med Wochenschr; 1955 May; 85(19):442-3. PubMed ID: 14385770
    [No Abstract]   [Full Text] [Related]  

  • 4. [Notes on the use of a new phenothiazine derivative, perphenazine, in neuro-psychiatric practice].
    LARICCHIA R; BASEVI A
    Minerva Med; 1958 May; 49(39, Suppl.):1993-5. PubMed ID: 13565614
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical and electroencephalographic findings during treatment of mental disorders with lithium salts].
    ANDREANI G; CASELLI G; MARTELLI G
    G Psichiatr Neuropatol; 1958; 86(1):273-328. PubMed ID: 13548573
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical & laboratory findings during treatment with large doses of meprobamate, with special reference to the EEG & changes induced in the autonomic nervous system].
    MENGOLI G; MACCAGNANI G
    Rass Studi Psichiatr; 1958; 47(1):67-72. PubMed ID: 13554943
    [No Abstract]   [Full Text] [Related]  

  • 7. [Epileptic crises and electroencephalographic changes during chlorpromazine therapy].
    MONTASSUT M; CHERTOK L; LEROY C
    Ann Med Psychol (Paris); 1955 May; 113 1(5):804-7. PubMed ID: 14388371
    [No Abstract]   [Full Text] [Related]  

  • 8. [Preliminary note on the use of perphenazine (trilafon Schering) in severe psychoses].
    CALLENS M
    Acta Neurol Psychiatr Belg; 1958 Nov; 58(11):925-33. PubMed ID: 13616947
    [No Abstract]   [Full Text] [Related]  

  • 9. Some correlations between the electroencephalogram and normal and pathologic mental processes.
    Hughes JR
    Epilepsy Behav; 2009 Mar; 14(3):452-3. PubMed ID: 19341979
    [No Abstract]   [Full Text] [Related]  

  • 10. [Notes on liver function test in mental patients treated with promazine].
    PARDERA G
    Riv Patol Nerv Ment; 1957; 78(3):1106-8. PubMed ID: 13528805
    [No Abstract]   [Full Text] [Related]  

  • 11. Prochlorperazine in hospitalized and private psychiatric patients.
    WILCOX F
    Dis Nerv Syst; 1958 Mar; 19(3):118-21. PubMed ID: 13524118
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacology of perphenazine; a new highly active neuro-psychoplegic; preliminary note].
    ARRIGONI-MARTELLI E; KRAMER M
    Minerva Med; 1958 May; 49(39, Suppl.):2007-12. PubMed ID: 13565618
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of ambulatory and hospitalized psychiatric patients with trilafon.
    AYD FJ
    Dis Nerv Syst; 1957 Oct; 18(10):394-7. PubMed ID: 13473680
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of promazine in mental syndromes.
    AZIMA H; DUROST H
    Can Med Assoc J; 1957 Mar; 76(6):442-6. PubMed ID: 13413759
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the use of promazine in acute and chronic nervous and mental disturbances.
    BURDINE WE; SHIPLEY TE; PAPAS AT
    J Med Assoc Ga; 1957 Apr; 46(4):171-3. PubMed ID: 13416819
    [No Abstract]   [Full Text] [Related]  

  • 16. [Modifications in the EEG of mental patients subjected to the effects of a phenothiazine derivative (largactil)].
    SANGUINETI I; NEGRI V; LARICCHIA R
    Riv Neurol; 1953; 23(4):513-34. PubMed ID: 13156445
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacologically induced Parkinson-like signs as index of the therapeutic potential.
    KARN WN; KASPER S
    Dis Nerv Syst; 1959 Mar; 20(3):119-22. PubMed ID: 13639829
    [No Abstract]   [Full Text] [Related]  

  • 18. The neuroleptic action and effectiveness of proclorperazine in psychiatric disorders.
    FREYHAN FA
    Psychiatr Res Rep Am Psychiatr Assoc; 1958 Mar; 9():32-45. PubMed ID: 13567917
    [No Abstract]   [Full Text] [Related]  

  • 19. [Complex evaluation in correction of mental disorders in patients with coronary artery disease].
    Kiriukhin OL; Gasanov NA; Rakita DR
    Klin Med (Mosk); 2007; 85(8):29-33. PubMed ID: 17926486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term treatment of mental disorders with high doses of phenothiazines].
    van PAASSEN ; RONNER HJ
    Ned Tijdschr Geneeskd; 1959 Oct; 103():2201-3. PubMed ID: 14429630
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.